Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy

Abstract

This study provides Class II evidence that EZG(RTG) 1,200 mg/day is effective as adjunctive therapy in adults with partial-onset seizures with or without secondary generalization.